Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone.
about
Sorrell v. IMS Health: issues and opportunities for informaticiansStimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS)Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.Impact of a health safety warning and prior authorisation on the use of piroxicam: a time-series study.Impact of safety-related regulatory action on clinical practice: a systematic review.Assessing cardiovascular drug safety for clinical decision-making.Methodological gaps in the assessment of risk minimization interventions: a systematic review.Review of toxicity and trends in the use of tiagabine as reported to US poison centers from 2000 to 2012.Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a countrywide study in Portugal.Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan.Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administration.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.Impact of an intervention on the prescription of aliskiren after new evidence on safety reported.
P2860
Q28709485-35217CF9-366C-4A58-A13F-06922602194AQ34389980-3C4F4B5D-707C-4DF8-8F7C-321E290C3AB2Q35827072-CCA7B9F1-F854-4F06-9061-29DFD0D08437Q35928690-211F1229-C0A2-45A5-B2C5-77F2938DFC0DQ37974880-6C736FC6-7593-49DE-9E60-AD92D727BD61Q38000336-5C73DEEC-E69C-44B7-8B1F-492C6CD63C3DQ38099504-C4627B0A-BCEF-4539-BB37-CE0AF6A109E7Q38195003-7CBCC4EC-8EAA-4D3D-8AC6-8E7500CA8078Q38397026-B51ADFC5-8695-4B79-BC0C-1243502A1239Q39711572-C56CD606-ED26-4C0B-8127-C7409398BE8AQ42876103-115F2D48-E931-482C-9CC3-96996CA9FE25Q43799079-86E1649C-5B42-4DB7-962C-B04DA0473370Q47653552-935E6001-9BFF-457D-AD19-04B087CEFCF4Q51061508-F6C64BA9-3AD8-4109-A002-65A94400E351
P2860
Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Impact of safety warnings on d ...... of cisapride and troglitazone.
@en
Impact of safety warnings on d ...... of cisapride and troglitazone.
@nl
type
label
Impact of safety warnings on d ...... of cisapride and troglitazone.
@en
Impact of safety warnings on d ...... of cisapride and troglitazone.
@nl
prefLabel
Impact of safety warnings on d ...... of cisapride and troglitazone.
@en
Impact of safety warnings on d ...... of cisapride and troglitazone.
@nl
P2093
P2860
P1433
P1476
Impact of safety warnings on d ...... of cisapride and troglitazone.
@en
P2093
Julie J Wilkinson
Paul S Cady
Rex W Force
P2860
P304
P356
10.1592/PHCO.24.11.978.36136
P407
P577
2004-08-01T00:00:00Z